Dasafav 20 mg Tablet
  1. Home
  2. Pharma Products
  3. Aureate Healthcare Pvt Ltd
  4. Dasafav 20 mg Tablet

Dasafav 20 mg Tablet

Dasafav 20 mg Tablet contains dasatinib, an oral anticancer medicine used to treat certain blood cancers. It is mainly used for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib works by blocking abnormal proteins that support the growth of leukemia cells.

BUY NOW

Category

Dasafav 20 mg Tablet is a tyrosine kinase inhibitor prescribed for eligible patients with specific forms of leukemia. Dasatinib inhibits BCR-ABL and other kinase proteins involved in the growth and survival of abnormal blood cells. It can be taken with or without food according to the prescribed treatment schedule. Regular blood tests and medical monitoring are important during therapy to assess blood counts, treatment response, and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 20 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer/Marketer Aureate Healthcare Pvt Ltd

Product Also Known As

Dasafav 20 mg Tablet, Dasatinib 20 mg Tablet, Dasafav Dasatinib Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet, Tyrosine Kinase Inhibitor Tablet